AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2022
Nov 17, 2022
31542_dirs_2022-11-17_23dea615-a3cc-4ae0-a193-81ce9db95992.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-11-15
Reporting Person: O'Keeffe Charles B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-15 | Common stock, par value $0.001 per share | S | 87985 | $16.037 | Acquired | 565057 | Direct |
Footnotes
F1: Shares were sold for personal reasons and not as a result of any disagreement with the Company. Mr. O'Keeffe remains an officer of the Company.
F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.00 to $16.18 per share.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30